Lorenzo Rossaro, M.D.
Gastroenterology and Hepatology
- Chief of Gastroenterology and Hepatology
UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817
UC Davis Medical Group - Elk Grove
8110 Laguna Blvd.
Elk Grove, CA 95758
Additional Phone Numbers
Lorenzo Rossaro is an internationally recognized authority on liver disease (hepatitis C, acute liver failure and cirrhosis). He received his medical training in his native Italy and the United States, where he was a Fulbright scholar. Dr. Rossaro has contributed to a management guide for fulminant hepatic failure, and his contributions to innovative treatments for hepatitis C that appeared in the New England Journal of Medicine, Gastroenterology, and Hepatology. Dr. Rossaro's research focuses on complications of liver disease. He also is studying telemedicine as a tool to close the gap of access to specialty care from rural areas.
Gastroenterology and Hepatology
M.D., University of Padova School of Medicine, Padova, Italy, 1982
University of Padova School of Medicine, Padova, Italy, 1982-86
University of Pittsburgh, Pittsburgh, Pennsylvania, 1986-88
Veterans Administration Medical Center, Brooklyn, New York, 1982
American Board of Internal Medicine, 2007
American Board of Internal Medicine, Gastroenterology and Hepatology, 1999
American Association for the Study of Liver Diseases
American Association of Gastroenterology
American College of Gastroenterology
European Association for Gastroenterology and Endoscopy
European Society for Organ Transplantation
North Italian Transplant Program
Society of Magnetic Resonance in Medicine
The Society for Organ Sharing
The Transplantation Society
Select Recent Publications
Giorgini, A., F. Capsoni, M. Podda, A. LIeo, P.M. Battezzati, A.M. Ongari, C. Selmi, A. Benetti, F. Malinverno, L. Rossaro, M.E. Gershwin, and M. Zuina. Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis. Annals of the New York Academy of Sciences, 1173:847-857, 2009.
Harrison, S.A., L. Rossaro, K.Q. Hu, K. Patel, H.L. Tillmann, S. Dhaliwal, D.M. Torres, K. Koury, V. Goteti, c.A. Brass, S. Noviello, J.K. Albrecht, J.G. McHutchison, and M.S. Sulkowski. Relationship of the Use of Stat ins and Elevated Low-Density Lipoprotein (LDL) or Total Cholesterol (TC) to Virologic Response in Patients Treated for Hepatitis C Virus (HCV) in the Ideal Study. Hepatology, 50(4 Suppl):85A, 2009.
Kwo, P.Y., E. Lowitz, J. McCone, E.R. Schiff, J.M. Vierling, D. Pound, M. Davis, J.S. Galati, S.C. Gordon, N. Ravendhran, L. Rossaro, F.H. Anderson, I.M. Jacobson, R Rubin, K. Koury, N. Boparai, E.!. Chaudhri, C.A. Brass, and J.K. Albrecht. High Sustained Virologic Response (SVR) in Genotype 1 (G 1) Null Responders to Peg-Interferon Alfa-2B (P) Plus Ribavirin (R) when treated with Boceprevir (BOC) Combination Therapy. Hepatology, 50(4 Suppl):72A, 2009.
Medici V., M.C.D. Virata, J.M. Peerson, T. Tonjes, S. Stabler, A. Albanese, C.L. Bowlus, S. Devaraj, E.A. Panacek, N. Rahim, J.R Richards, L. Rossaro, S.W. French, C.H. Halsted. Methionine metabolites in alcoholic patients in relation to clinical disease and hepatic pathology. Alcoholism: Clinical and Experimental Research, 33(6 SuppI26A):26A, 2009.
Rodriquez-Torres, M., L.J. Jeffers, M.Y. Sheikh, L. Rossaro, V. Ankoma-Sey, F.M. Hamzeh, P. Martin on behalf of the Latino Study Group. Virologic Responses to Peginterferon Alfa-2A1 Ribavirin in Treatment-Naive Latino vs Non-Latino Caucasians Infected with HCV Genotype 1: The Latino Study. Journal of Hepatology, 48(2):S311, 2008.
Rossaro L., C. Aoki, J. Yuk, C. Prosser, J. Goforth, and F. Martinez. The Evaluation of Patients with Hepatitis C Living in Rural California via Telemedicine. Telemed J E Health, 14(10):1127-1129, 2008.
Seremba E., C.M. Sanders, M.K. Jain, T.J. Davern, L. Rossaro, R.J. Fontana, S. Han and W.M. Lee. Use of Nucleoside Analogues in HBV Related Acute Liver Failure. Hepatology, 46(4):75A, 2007.
Lee W.M., L. Rossaro, RJ. Fontana, A.M. Larson, R.R Stravitz, T.J. Davern, L.S. Hynan, J.S. Reish and P.R. Robuck. Intravenous NAcetylcysteine Improves Spontaneous Survival in Early Stage Nonacetaminophen Acute Liver Failure. Hepatology, 46(4):71A, 2007.
Medici V., J. Nakai, K. Fisher, L. Rossaro, and F. J. Meyers. Simultaneous Provision of Pre-Operative Paliative Care for Patients Awaiting Liver Transplantation. Hepatology, 44(4):A376, 2006.
Polson J., L. P. James, T. J. Davern, L. Hynan, L. Rossaro, A. M. Larson, C. Pezzia, and W. M. Lee. Acetaminophen as a Co-Factor in Acute Liver Failure Due to Viral Hepatitis Determined by Measurement of Acetaminophen-Protein Adducts. Gastroenterology, 130(4):A772, 2006.
Rossaro L., C. C. Chambers, J. Polson, C. L. Bowlus, L. S. Hynan, R J. Fontana, A. O. Shakil, T. Stravitz, M. L. Schilsky, E. J. Hay, W. M. Lee, and the ALF Study Group. Performance of MELD in Predicting Outcome in Acute Liver Failure. Gastroenterology, 128(4):A705, 2005.
Rossaro L., C. C. Chambers, J. Polson, C. L. Bowlus, L. S. Hynan, R J. Fontana, O. A. Shakil, R. T. Stravitz, M. L. Schilsky, E. J. Hay, and W. M. Lee. MELD Predicts Survival in Acetaminophen Related Acute Liver Failure. American Journal of Transplantation, 5:A219, 2005.